Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-13

Clinical Trial Update: Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating lipid emulsions to reduce neonatal parenteral nutrition-associated cholestasis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lipid emulsions for parenteral nutrition

Snippet

Sponsor: Centro Hospitalar de Lisboa Central | Conditions: Intrahepatic, Cholestasis | Phase 4 | Status: TERMINATED